Harmonize your drug development efforts with real-time patient insights. Collaboration with disease communities at every stage of development integrates real-world value, to inform trial design, patient recruitment, and retention. An engaged patient community who informs your clinical efforts from the outset will be your most loyal army of champions when you need them most to amplify data readouts, engage in regulatory activity and beyond.
With decades of industry and personal, lived patient advocacy experience, we efficiently operationalize your patient engagement efforts at every stage of the drug development continuum to maximize the value you create for patients.
For a pre-phase 2 project, the cumulative impact of a patient engagement activity that avoids one protocol amendment and improves enrollment, adherence, and retention is an increase in net present value (NPV) of $62MM ($65MM for pre-phase 3) and an increase in ENPV of $35MM ($75MM for pre-phase 3). Compared with an investment of $100,000 in patient engagement, the NPV and ENPV increases can exceed 500-fold the investment.
Experience
Through collaboration with underserved patient communities, we’ve been able to impact favorable public policy, develop first-of-kind non-profits for rare diseases, and impactfully support clinical trials.
PAS has delivered innovative and value-added work on behalf of leading life science clients and healthcare professionals for years, and we’d be honored to help your organization do the same.
Columbia University, Irving Medical Center
IgG4ward! Foundation
wAIHA Warriors would not be the resource it is today for patients with Autoimmune Hemolytic Anemia without the expertise of the Patient Advocacy Strategies team. By including patients, medical experts, and clinical researchers in their strategic vision, PAS elevated wAIHA Warriors as the leading resource for educational information, clinical trials, and mental health assistance materials as patients navigate this rare disease.
